XML 15 R2.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Balance Sheets (unaudited) - USD ($)
$ in Thousands
Sep. 30, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 580,013 $ 525,540
Short-term marketable debt securities 0 314,438
Accounts receivable, net 115,585 110,253
Inventory, net 90,489 71,083
Prepaid expenses and other current assets, net 42,798 33,800
Total current assets 828,885 1,055,114
Restricted cash 109,502 104,215
Property and equipment, net 124,609 136,813
Right-of-use assets, net 163,550 142,265
Intangible assets, net 5,477 6,760
Goodwill 3,290 3,290
Other assets, net 41,473 37,152
Total Assets 1,276,786 1,485,609
Current liabilities:    
Accounts payable 20,142 38,551
Accrued compensation 98,209 83,219
Accrued expenses 71,707 68,345
Deferred revenue 46,861 35,468
Total current liabilities 236,919 225,583
Convertible senior notes, net, principal amount of $1,090,660 and $1,150,000 as of September 30, 2025 and December 31, 2024, respectively 1,114,594 1,142,547
Long-term operating lease liabilities 185,387 164,292
Other long-term liabilities 94,359 92,834
Total Liabilities 1,631,259 1,625,256
Commitments and contingencies
Stockholders’ deficit:    
Preferred stock, par value of $0.00001 per share; 10,000,000 shares authorized, no shares issued and outstanding as of September 30, 2025 and December 31, 2024 0 0
Common stock, par value of $0.00001 per share; 350,000,000 shares authorized; 125,982,066 and 123,994,006 shares issued as of September 30, 2025 and December 31, 2024; and 125,005,715 and 123,994,006 shares outstanding as of September 30, 2025 and December 31, 2024, respectively 1 1
Treasury stock, at cost, 976,351 shares as of September 30, 2025 (45,010) 0
Additional paid-in capital 2,560,814 2,443,788
Accumulated other comprehensive loss (4,260) (5,201)
Accumulated deficit (2,866,018) (2,578,235)
Total Stockholders’ Deficit (354,473) (139,647)
Total Liabilities and Stockholders’ Deficit $ 1,276,786 $ 1,485,609